Stabile LP - Search Results

1

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.

Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Patel R, Hu EH, Sadeghi S, Parikh RJ, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang HJ, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ. Garon EB, et al. Among authors: stabile lp. Lung Cancer. 2018 Sep;123:91-98. doi: 10.1016/j.lungcan.2018.06.013. Epub 2018 Jun 22. Lung Cancer. 2018. PMID: 30089602 Free PMC article. Clinical Trial.

2

Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen.

Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM. Stabile LP, et al. Cancer Res. 2002 Apr 1;62(7):2141-50. Cancer Res. 2002. PMID: 11929836

3

Sex and gender differences in lung cancer.

Stabile LP, Siegfried JM. Stabile LP, et al. J Gend Specif Med. 2003;6(1):37-48. J Gend Specif Med. 2003. PMID: 12661176 Review.

4

Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.

Stabile LP, Lyker JS, Huang L, Siegfried JM. Stabile LP, et al. Gene Ther. 2004 Feb;11(3):325-35. doi: 10.1038/sj.gt.3302169. Gene Ther. 2004. PMID: 14737093

5

Elevated hepatocyte growth factor level correlates with poor outcome in early-stage and late-stage adenocarcinoma of the lung.

Siegfried JM, Luketich JD, Stabile LP, Christie N, Land SR. Siegfried JM, et al. Among authors: stabile lp. Chest. 2004 May;125(5 Suppl):116S-9S. doi: 10.1378/chest.125.5_suppl.116s. Chest. 2004. PMID: 15136456 No abstract available.

6

Estrogen receptor pathways in lung cancer.

Stabile LP, Siegfried JM. Stabile LP, et al. Curr Oncol Rep. 2004 Jul;6(4):259-67. doi: 10.1007/s11912-004-0033-2. Curr Oncol Rep. 2004. PMID: 15161576 Review.

7

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Stabile LP, et al. Cancer Res. 2005 Feb 15;65(4):1459-70. doi: 10.1158/0008-5472.CAN-04-1872. Cancer Res. 2005. PMID: 15735034

8

Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer.

Stabile LP, Lyker JS, Land SR, Dacic S, Zamboni BA, Siegfried JM. Stabile LP, et al. Carcinogenesis. 2006 Aug;27(8):1547-55. doi: 10.1093/carcin/bgl003. Epub 2006 Mar 2. Carcinogenesis. 2006. PMID: 16513678

9

Mutation and polymorphism in the EGFR-TK domain associated with lung cancer.

Zhang W, Stabile LP, Keohavong P, Romkes M, Grandis JR, Traynor AM, Siegfried JM. Zhang W, et al. Among authors: stabile lp. J Thorac Oncol. 2006 Sep;1(7):635-47. J Thorac Oncol. 2006. PMID: 17409930 Free article.

10

Signaling pathways involved in cyclooxygenase-2 induction by hepatocyte growth factor in non small-cell lung cancer.

Siegfried JM, Gubish CT, Rothstein ME, Queiroz de Oliveira PE, Stabile LP. Siegfried JM, et al. Among authors: stabile lp. Mol Pharmacol. 2007 Sep;72(3):769-79. doi: 10.1124/mol.107.034215. Epub 2007 Jun 5. Mol Pharmacol. 2007. PMID: 17550984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters